SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: S-3
Document Type: EX-1.2
Date Filed: 2025-11-26
Accession Number: 0001213900-25-115554
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025115554/ea026681201ex1-2_synergy.htm

Chunk 0 of 18
Word Count: 1392
Character Count: 8615

Document Content:

Exhibit 1.2

SYNERGY CHC CORP.

Common Stock

($0.00001 par value per share)

SALES AGREEMENT

November 26, 2025

Roth Capital Partners, LLC

888 San Clemente Drive, Suite 400

Newport Beach, CA 92660

Bancroft Capital LLC

501 Office Center Drive, Suite 130

Fort Washington, PA 19034

Ladies and Gentlemen:

Synergy CHC Corp., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”)
with Roth Capital Partners, LLC (the “Lead Agent”) and Bancroft Capital LLC (an “Agent” and collectively
with the Lead Agent, the “Agents”), as follows:

1. Issuance
and Sale of Shares. The Company agrees that, from time to time during the term of this Agreement, on the terms and subject to the
conditions set forth herein, it may issue and sell through or to the Agents, as sales agents or principals, shares (the “Placement
Shares”) of common stock of the Company, $0.00001 par value per share (the “Common Stock”), having an aggregate
offering price of up to $5,690,000, provided, however, that in no event shall the Company issue or sell through the Agents such
number of Placement Shares that (a) exceeds the number or dollar amount of shares of Common Stock that may be sold pursuant to the Prospectus
Supplement (as defined below), or (b) exceeds the number of authorized but unissued shares of Common Stock of the Company (the “Maximum
Amount”). Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitations
set forth in this Section 1 on the number or dollar amount of Placement Shares issued and sold under this Agreement shall be the
sole responsibility of the Company and that the Agents shall have no obligation in connection with such compliance. The issuance and sale
of Placement Shares through or to the Agents will be effected pursuant to the Registration Statement (as defined below) to be filed by
the Company and after such Registration Statement has been declared effective by the Securities and Exchange Commission (the “Commission”),
although nothing in this Agreement shall be construed as requiring the Company to use the Registration Statement to issue any Placement
Shares.

The Company will file on the
date hereof, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (the
“Securities Act”), with the Commission a registration statement on Form S-3, including a base prospectus, relating
to certain securities, including the Placement Shares to be issued from time to time by the Company, and which incorporates by reference
documents that the Company has filed or will file in accordance with the provisions of the Securities Exchange Act of 1934, as amended,
and the rules and regulations thereunder (the “Exchange Act”). The Company has prepared a prospectus supplement specifically
relating to the Placement Shares (the “Prospectus Supplement”) to the base prospectus included as part of such registration
statement to be filed concurrently with the base prospectus. The Company will furnish to the Agents, for use by the Agents, copies of
the prospectus included as part of such registration statement, as supplemented by the Prospectus Supplement, relating to the Placement
Shares. Except where the context otherwise requires, such registration statement, and any post-effective amendment thereto, including
all documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as
defined below) subsequently filed with the Commission pursuant to Rule 424(b) under the Securities Act or deemed to be a part of such
registration statement pursuant to Rule 430B of the Securities Act, or any subsequent registration statement on Form S-3 filed pursuant
to Rule 415(a)(6) under the Securities Act by the Company to cover any Placement Shares, is herein called the “Registration Statement.”
The base prospectus, including all documents incorporated therein by reference, included in the Registration Statement, as it may be supplemented
by the Prospectus Supplement, in the form in which such prospectus and/or Prospectus Supplement have most recently been filed by the Company
with the Commission pursuant to Rule 424(b) under the Securities Act, together with any then issued Issuer Free Writing Prospectus (defined
below), is herein called the “Prospectus.” Any reference herein to the Registration Statement, the Prospectus or any
amendment or supplement thereto, shall be deemed to refer to and include the documents incorporated or deemed to be incorporated by reference
therein, and any reference herein to the terms “amend,” “amendment” or “supplement” with respect to
the Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document
with the Commission deemed to be incorporated by reference therein (the “Incorporated Documents”). For purposes of
this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed
to include any copy filed with the Commission pursuant to its Electronic Data Gathering Analysis and Retrieval System (“EDGAR”).

2. Placements.
Each time that the Company wishes to issue and sell Placement Shares hereunder (each, a “Placement”), it will notify
the Lead Agent by email notice (or other method mutually agreed to in writing by the parties hereto) of the number or dollar value of
Placement Shares, the time period during which sales are requested to be made, any limitation on the number of Placement Shares that may
be sold in any one day and any minimum price below which sales may not be made (a “Placement Notice”), the form of
which is attached hereto as Schedule 1. The Placement Notice shall originate from any of the individuals from the Company set forth on
Schedule 3 (with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of
the individuals from the Lead Agent set forth on Schedule 3, as such Schedule 3 may be amended from time to time. The Placement Notice
shall be effective unless and until (i) the Lead Agent declines to accept the terms contained therein for any reason, in its sole discretion,
(ii) the entire amount of the Placement Shares thereunder has been sold, (iii) the Company suspends or terminates the Placement Notice
or (iv) the Agreement has been terminated under the provisions of Section 12. The amount of any discount, commission or other compensation
to be paid by the Company to the Lead Agent in connection with the sale of the Placement Shares shall be calculated in accordance with
the terms set forth in Schedule 2. It is expressly acknowledged and agreed that neither the Company nor the Agents will have any obligation
whatsoever with respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to the Lead Agent
and the Lead Agent does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified
therein and herein. In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the
Placement Notice will control.

3. Sale
of Placement Shares. Subject to the provisions of Section 5(a), the Lead Agent, for the period specified in the Placement Notice,
will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws,
rules and regulations and the rules of the Nasdaq Stock Market (the “Exchange”), to sell the Placement Shares up to
the amount specified, and otherwise in accordance with the terms of such Placement Notice. The Lead Agent will provide written confirmation
to the Company no later than the opening of the Trading Day (as defined below) immediately following the Trading Day on which they have
made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day, the compensation payable by the
Company to the Lead Agent pursuant to Section 2 with respect to such sales, and the Net Proceeds (as defined below) payable to
the Company, with an itemization of the deductions made by the Lead Agent (as set forth in Section 5(b)) from the gross proceeds
that the Lead Agent receives from such sales. Subject to the terms of the Placement Notice, the Lead Agent may sell Placement Shares by
any method permitted by law deemed to be an “at the market offering” as defined in Rule 415 of the Securities Act.

4. Suspension
of Sales.